Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. (IKT) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 22 transactions totaling $3.1M, demonstrating a bullish sentiment with $3.1M in net insider flow. The most recent transaction on Feb 21, 2026 involved a transaction of 19,089 shares valued at $0.
IKT Insider Activity Summary
Who Is Buying IKT Stock?
No significant insider buying has been recorded for IKT in the recent period.
Who Is Selling IKT Stock?
No significant insider selling has been recorded for IKT in the recent period.
Is Inhibikase Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for IKT is bullish with an Insider Alignment Score of 100/100 and a net flow of $3.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
IKT Frequently Asked Questions
Understanding IKT Insider Activity
Insider trading at Inhibikase Therapeutics, Inc. (IKT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading IKT stock, having executed 22 transactions in the past 90 days. The most active insider is Frank M. Sands (Executive), who has made 1 transactions totaling $3.0M.
Related Tools
Track Inhibikase Therapeutics, Inc. Insider Activity
Get notified when executives and directors at IKT file new Form 4 transactions